Login / Signup

Association of kidney function with SGLT2 inhibitor discontinuation among United States Veterans.

Jesse C IkemeErin MaddenJulio Alejandro Lamprea-MontealegreChi D ChuMichael G ShlipakIan Ellis McCoyMichelle M Estrella
Published in: Clinical journal of the American Society of Nephrology : CJASN (2024)
A substantial proportion of patients experience SGLT2i discontinuation within a year of initiation. Persons with lower eGFR had higher discontinuation rates; however, this trend attenuated over time. Additional studies identifying determining factors of discontinuation are needed to fully realize the benefits of SGLT2i.
Keyphrases
  • end stage renal disease
  • small cell lung cancer
  • ejection fraction
  • chronic kidney disease
  • epidermal growth factor receptor
  • prognostic factors
  • tyrosine kinase
  • patient reported outcomes